Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment

Hypercalcemia of malignancy (HCM), caused primarily by tumor-induced bone resorption, may lead to renal failure, coma, and death. Although HCM can be treated with intravenous bisphosphonates, patients may not respond or may relapse on therapy. Denosumab binds the bone resorption mediator RANKL. In t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Hu, Mimi I., Glezerman, Ilya, Leboulleux, Sophie, Insogna, Karl, Gucalp, Rasim, Misiorowski, Waldemar, Yu, Bennett, Ying, Wendy, Jain, Rajul K.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2013
Fag:
Brief Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776443/
https://ncbi.nlm.nih.gov/pubmed/23990665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt225
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker